Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism. Results from test-T1D randomized clinical trial
Chillarón, J.J., Pedro-Botet, J., Fernández-Miró, M., Albareda, M., Vila, L., Benaiges, D., Le-Roux, J.A. FloresVolume:
252
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2016.07.420
Date:
September, 2016
File:
PDF, 240 KB
english, 2016